Investor attention is turning to Moelis (MC) ahead of its upcoming earnings release, as expectations for year over year earnings growth and a potential earnings beat focus renewed scrutiny on the stock’s recent performance.
See our latest analysis for Moelis.
Moelis’s recent share price has softened, with a 7.93% decline year to date and a 5.31% fall over the past week, even though the 3 year total shareholder return of 55.64% and 5 year total shareholder return of 43.58% show that longer term holders have still seen gains. This suggests that the current weakness reflects cooler near term momentum as investors reassess the stock ahead of the earnings release.
If expectations around Moelis have you reassessing your watchlist, this could be a good moment to see what else is moving and uncover 17 top founder-led companies
Moelis looks like a solid advisory business on the surface. However, the recent share price pullback raises a different issue: are you paying a fair price today for that quality, or stretching for earnings optimism ahead of results?
Most Popular Narrative: 7.6% Undervalued
The most followed narrative on Moelis currently points to a fair value of $71 against the last close at $65.57, and sets out a detailed earnings and revenue roadmap that investors will want to understand before the earnings print.
The analysts have a consensus price target of $71.0 for Moelis based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $86.0, and the most bearish reporting a price target of just $58.0.
Want to see what is sitting behind that $71 fair value for Moelis? The narrative leans heavily on a specific mix of revenue growth, margin shaping and a future earnings multiple that is not reflected in the current share price. The full story is in how those moving parts are expected to line up over the next few years.
Result: Fair Value of $71 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, the Moelis story also carries clear pressure points, including rising hiring and compensation costs, as well as intense competition that could squeeze margins if deal activity slows.
Find out about the key risks to this Moelis narrative.
Another View On Moelis Valuation
The earlier fair value of $71 for Moelis hinges on earnings forecasts and the current share price at $65.57, which implies the stock trades about 29.5% below an internal estimate of fair value. That discount sounds attractive, but it also raises a question about how much risk the market is pricing in.
Our DCF model takes a different route to that conclusion. It values Moelis at $92.99 based on projected future cash flows, which is well above both the current price and the $71 narrative fair value. If the cash flow view is right, is the market underestimating the staying power of Moelis earnings, or are the inputs to this model simply too generous?
Look into how the SWS DCF model arrives at its fair value.
Next Steps
With sentiment on Moelis clearly mixed, this is a moment to move quickly, test the assumptions in the data, and weigh both upside and downside using the 2 key rewards and 1 important warning sign
Looking for more investment ideas beyond Moelis?
Do not stop with Moelis. Broaden your watchlist using a few focused stock ideas that match different goals, risk levels, and income needs.
- Target potential mispricing by scanning for quality companies trading on appealing valuations through the 38 high quality undervalued stocks.
- Strengthen your income stream by hunting for companies with higher yields and resilient payouts via the 7 dividend fortresses.
- Dial back risk by zeroing in on businesses with healthier finances using the 79 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com